Tuesday, November 5, 2024
Subscribe American Journal of Medicine Free Newsletter
VideoAlpert's videosWarfarin or DOACs after Bariatric Surgery? (video)

Warfarin or DOACs after Bariatric Surgery? (video)

bleedingCardiologyCardiovascular DiseaseClinical ResearchCommentaryDrugsWarfarinPatient CareVideoAlpert's videos
463

There are no randomized controlled trials comparing direct oral anticoagulants (DOACs) with warfarin after bariatric surgery. In this video, AJM Editor-in Chief Joseph S. Alpert, MD reviews a new meta-analysis on this topic.

You can read “Thromboembolism, Bleeding, and Mortality Incidence of Direct Oral Anticoagulants Versus Warfarin Postbariatric Surgery: A Systemic Review and Meta-Analysis” by Krutika et al in the November 2021 issue of the American Journal of Medicine at amjmed.com.

 

Previous article
Trends in Mortality of Patients Hospitalized with High-Risk PE (video)
Next article
Are Nasal Feeding Tubes Safer? (video)

Latest Posts

lupus

Sarcoidosis with Lupus Pernio in an Afro-Caribbean Man

American Journal of Medicine 0
A 54-year-old man of Afro-Caribbean ancestry presented with a 2-month history of nonproductive cough, 10-day history of constant subjective fevers, and a 1-day history...
Flue Vaccine

Flu Vaccination to Prevent Cardiovascular Mortality (video)

Cardiology 0
"Influenza can cause a significant burden on patients with coronary artery disease," write Barbetta et al in The American Journal of Medicine. For this...
varicella zoster

Varicella Zoster Virus-Induced Complete Heart Block

Case Studies 0
Complete heart block is usually caused by chronic myocardial ischemia and fibrosis but can also be induced by bacterial and viral infections. The varicella...
Racial justice in healthcare

Teaching Anti-Racism in the Clinical Environment

medical education 0
"Teaching Anti-Racism in the Clinical Environment: The Five-Minute Moment for Racial Justice in Healthcare" was originally published in the April 2023 issue of The...
Invisible hand of the market

The ‘Invisible Hand’ Doesn’t Work for Prescription Drugs

Commentary 0
Pharmaceutical innovation has been responsible for many “miracles of modern medicine.” Reliance on the “invisible hand” of Adam Smith to allocate resources in the...
Joseph S. Alpert, MD

New Coronary Heart Disease Risk Factors

Alpert's Editorials 0
"New Coronary Heart Disease Risk Factors" by AJM Editor-in Chief Joseph S. Alpert, MD was originally published in the April 2023 issue of The...
Cardiovascular risk from noncardiac activities

Cardiac Risk Related to Noncardiac & Nonsurgical Activities

Clinical Research 0
"Assessment of Cardiovascular Risk for Noncardiac and Nonsurgical Activities" was originally published in the April 2023 issue of The American Journal of Medicine. Cardiovascular risk...
American Journal of Medicine Blog

The American Journal of Medicine (AJM) is an academic internal medicine journal. On the AJM blog, we publish articles that appear in the journal, as well as blog commentaries, letters, and comments published only on the blog.

www.AMJMed.com

editors@amjmed.org

Editor-in-Chief
Joseph S. Alpert MD
The University of Arizona
College of Medicine,
Tucson, AZ

Submit Your Manuscript to AJM

SUBMIT MANUSCRIPT
GUIDE FOR AUTHORS

New Version AJM App Available

For iPad and iPhone
DOWNLOAD AJM APP

Follow AJM on Facebook

American Journal of Medicine

Follow AJM on Twitter

© 2023 The American Journal of Medicine Blog. All Rights Reserved.

MORE STORIES
physical exam

How Strongly Do Physical Examination Estimates and Ultrasonographic Measurements of Liver...

antihypertensive drugs and lupus

Can RAS-Modifying Drugs Reduce CVD Risk in Lupus Patients? (video)

Recent Cannabis Research in AJM (video)